High-Potency Cannabis: America’s New Pastime and Psychiatry’s Next Challenge
High-potency cannabis psychiatric risks are increasingly relevant as these products are marketed for mental health conditions despite limited evidence. Clinicians must understand these risks to guide patients effectively. This article highlights the…
High-Potency Cannabis Linked to Dramatically Higher Risk of Psychotic Episodes
High-potency THC cannabis risk is strongly associated with increased chances of psychotic episodes. Research highlights that THC concentrations above 10-15% elevate this risk, particularly in adolescents and those with psychiatric history. Understanding…
Drug Reform Group Proposes Options to Address High-THC Marijuana Risks
High-thc cannabis policy options are being explored to address the risks associated with potent marijuana products. These options aim to reduce harm without returning to criminalization. Regulatory approaches include potency caps and enhanced labeling to…
Efficacy and Safety of High-THC Medicinal Cannabis Products: A Rapid Review
High-THC medicinal cannabis products are increasingly used for therapeutic purposes, characterized by THC concentrations of 16-22%. This rapid review evaluates their efficacy and safety profile based on recent clinical studies. Understanding high-thc…